10.1002/anie.201708867
Angewandte Chemie International Edition
COMMUNICATION
but their median relative intensity in the respective MS²-spectra is also
higher (Fig. 3C). An example spectrum is displayed in Fig. 3D. The
signals for the reporter ions (red) and of seven complementary ion
clusters (orange) are clearly visible with high relative intensities. For
identification of the peptide, multiple high intensity ions are available
(grey). Although the number of acquired MS2-scans was comparable
for the SOT- and TMT-samples (42169 for SOT, 46062 for TMT), the
peptide identification rate was lower for SOT-labelled peptides (20%
for SOT, 35% for TMT).
be particularly attractive for a targeted multiplexed approach.[20] The
most important properties of the SOT reagent 2 are that reporter ions
and complementary ion clusters are formed in parallel and that the
introduction of multiple tert-amino groups generates the expected
higher charge states which results in better peptide fragmentation. A
current drawback is that the SOT reagent leads to identification of
fewer peptides. The lower number is certainly caused by the currently
available software, which is not yet optimized for the SOT reagent. In
addition, the reagent increases the charge state, which could be
another limiting factor. Software optimization and synthesis of a
reagent that lacks the tertiary amine, can solve these problems.
Research in this direction is ongoing.[21]
To investigate whether our new reagent reduces the ratio distortion
effect, we performed an experiment in which a 1:1 labelled mixture of
HEK-lysate served as a background. Into this background, a labelled
bovine serum albumin (BSA) digest was added in a 4:1 ratio in a low
quantity (Fig. 4A). This ensures that only a small amount of BSA
peptides gets selected for isolation and fragmentation in a large
background of 1:1 labelled human peptides. This should give a large
ratio distortion. As observed previously in similar datasets with strong
distortion,[16] the normalized median reporter ion ratio for the BSA
peptides is 1.15 in case of the SOT-sample and 1.11 in case of the
TMT-sample, showing the massive distortion of the ratio towards 1:1
(Fig. 4B). We next studied the same SOT-dataset regarding the
complementary ion clusters of the BSA peptides.
Acknowledgements
We thank the Deutsche Forschungsgemeinschaft for financial support
via SPP1784, CA275 and GRK2062. We thank the
Bundesministerium für Bildung und Forschung (BMBF) for additional
support by the Excellence Cluster CiPSM. Further support from the
European Union through the Marie Curie International Training and
Mobility Network “Clickgene” (grant No. 642023) is acknowledged
M.S. thanks the Fonds der Chemischen Industrie for a predoctoral
fellowship.
Keywords: Peptide derivatization reagent, sulfoxide pyrolysis,
isobaric labelling, quantitative mass spectrometry,
complementary ion clusters, proteomics
[1] S. Goodwin, J. D. McPherson, W. R. McCombie, Nat. Rev. Genet. 2016,
17, 333-351.
[2] M. Beck, A. Schmidt, J. Malmstroem, M. Claassen, A. Ori, A. Szymborska,
F. Herzog, O. Rinner, J. Ellenberg, R. Aebersold, Mol. Syst. Biol. 2011, 7,
549.
Figure 4. A) Experiment to show quantification of a protein with strong ratio
distortion. HEK-lysate was labelled and mixed in a 1 to 1 ratio to serve as a
background. Bovine serum albumin (BSA) was labelled and a 4 to 1 ratio was
added into the background. Reporter ion intensities of BSA-peptides are highly
distorted in the sample. B) Quantification results for measured BSA-peptides.
Median reporter ion intensities of both TMT- and SOT-samples show a high
distortion, leading to the impression of a nearly 1 to 1 ratio. Complementary ion
cluster analysis results in a higher and therefore improved value of the BSA
peptide ratio. Thus, SOT complementary ion cluster analysis reduces ratio
distortion.
[3] M.-S. Kim, S. M. Pinto, D. Getnet, R. S. Nirujogi, S. S. Manda, R.
Chaerkady, A. K. Madugundu, D. S. Kelkar, R. Isserlin, S. Jain, J. K.
Thomas, B. Muthusamy, P. Leal-Rojas, P. Kumar, N. A. Sahasrabuddhe, L.
Balakrishnan, J. Advani, B. George, S. Renuse, L. D. N. Selvan, A. H. Patil,
V. Nanjappa, A. Radhakrishnan, S. Prasad, T. Subbannayya, R. Raju, M.
Kumar, S. K. Sreenivasamurthy, A. Marimuthu, G. J. Sathe, S. Chavan, K.
K. Datta, Y. Subbannayya, A. Sahu, S. D. Yelamanchi, S. Jayaram, P.
Rajagopalan, J. Sharma, K. R. Murthy, N. Syed, R. Goel, A. A. Khan, S.
Ahmad, G. Dey, K. Mudgal, A. Chatterjee, T.-C. Huang, J. Zhong, X. Wu, P.
G. Shaw, D. Freed, M. S. Zahari, K. K. Mukherjee, S. Shankar, A.
Mahadevan, H. Lam, C. J. Mitchell, S. K. Shankar, P. Satishchandra, J. T.
Schroeder, R. Sirdeshmukh, A. Maitra, S. D. Leach, C. G. Drake, M. K.
Halushka, T. S. K. Prasad, R. H. Hruban, C. L. Kerr, G. D. Bader, C. A.
Iacobuzio-Donahue, H. Gowda, A. Pandey, Nature 2014, 509, 575-581.
[4] N. Nagaraj, J. R. Wisniewski, T. Geiger, J. Cox, M. Kircher, J. Kelso, S.
Pääbo, M. Mann, Mol. Syst. Biol. 2011, 7, 548.
In 17 quantified peptides, 155 complementary ion clusters were
detected and used for quantification. Analyzing their intensities
provided a normalized median ratio of 2.3:1. The determined ratio is
by a factor of 2 closer to the expected 4:1 ratio, showing the
advantage of SOT complementary cluster analysis (SOTc).
In summary, we report the design of a new isobaric labelling reagent
that allows the efficient parallel formation of reporter ions and
complementary ion clusters for peptide quantification. The reagent
helps to reduce quantification errors caused by ratio distortion.
Particularly attractive is the efficient formation of complementary ion
clusters that results from fragmentations of the tag and the peptide
backbone. These ion-clusters enable multiple quantification events
per spectrum. Furthermore, due to the peptide-specific fragmentation,
we expect the resulting quantifications to be even more robust against
interference than when using the intact peptide complimentary ion
cluster. This enables more accurate determination of relative peptide
and hence protein abundances even in complex samples and might
[5] M. Uhlén, L. Fagerberg, B. M. Hallström, C. Lindskog, P. Oksvold, A.
Mardinoglu, Å. Sivertsson, C. Kampf, E. Sjöstedt, A. Asplund, I. Olsson, K.
Edlund, E. Lundberg, S. Navani, C. A.-K. Szigyarto, J. Odeberg, D.
Djureinovic, J. O. Takanen, S. Hober, T. Alm, P.-H. Edqvist, H. Berling, H.
Tegel, J. Mulder, J. Rockberg, P. Nilsson, J. M. Schwenk, M. Hamsten, K.
von Feilitzen, M. Forsberg, L. Persson, F. Johansson, M. Zwahlen, G. von
Heijne, J. Nielsen, F. Pontén, Science 2015, 347.
[6] E. F. Petricoin, K. C. Zoon, E. C. Kohn, J. C. Barrett, L. A. Liotta, Nat. Rev.
Drug Discovery 2002, 1, 683-695.
[7] S.-E. Ong, B. Blagoev, I. Kratchmarova, D. B. Kristensen, H. Steen, A.
Pandey, M. Mann, Mol. Cell. Proteomics 2002, 1, 376-386.
[8] S.-E. Ong, M. Mann, Nat. Protoc. 2007, 1, 2650-2660.
[9] J. Cox, M. Y. Hein, C. A. Luber, I. Paron, N. Nagaraj, M. Mann, Mol. Cell.
Proteomics 2014, 13, 2513-2526.
[10] A. Thompson, J. Schäfer, K. Kuhn, S. Kienle, J. Schwarz, G. Schmidt, T.
Neumann, C. Hamon, Anal. Chem. 2003, 75, 1895-1904.
This article is protected by copyright. All rights reserved.